title: DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane.
abstract: CRK belongs to a family of adaptor proteins that consist mostly of SH2 and SH3 domains. Far Western blotting with CRK SH3 has demonstrated that it binds to 135- to 145-, 160-, and 180-kDa proteins. The 135- to 145-kDa protein is C3G, a CRK SH3-binding guanine nucleotide exchange protein. Here, we report on the molecular cloning of the 180-kDa protein, which is designated DOCK180 (180-kDa protein downstream of CRK). The isolated cDNA contains a 5,598-bp open reading frame encoding an 1,866-amino-acid protein. The deduced amino acid sequence did not reveal any significant homology to known proteins, except that an SH3 domain was identified at its amino terminus. To examine the function of DOCK180, a Ki-Ras farnesylation signal was fused to the carboxyl terminus of DOCK180, a strategy that has been employed successfully for activation of adaptor-binding proteins in vivo. Whereas wild-type DOCK180 accumulated diffusely in the cytoplasm and did not have any effect on cell morphology, farnesylated DOCK180 was localized on the cytoplasmic membrane and changed spindle 3T3 cells to flat, polygonal cells. These results suggest that DOCK180 is a new effector molecule which transduces signals from tyrosine kinases through the CRK adaptor protein.
authors.affiliation: Department of Pathology, National Institute of Health, Toyama, Shinjuku-ku, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Hasegawa
authors.forename: E
authors.initials: E
authors.lastname: Kiyokawa
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Nagashima
authors.forename: N
authors.initials: N
authors.lastname: Gotoh
authors.forename: M
authors.initials: M
authors.lastname: Shibuya
authors.forename: T
authors.initials: T
authors.lastname: Kurata
authors.forename: M
authors.initials: M
authors.lastname: Matsuda
mesh_terms: D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D001692:Biological Transport; D015153:Blotting, Western; D002462:Cell Membrane / Q000187:drug effects* / Q000378:metabolism; D003001:Cloning, Molecular; D066246:ErbB Receptors / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D050736:Oncogene Protein v-crk; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics / Q000494:pharmacology*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D015682:Retroviridae Proteins, Oncogenic / Q000235:genetics / Q000378:metabolism*; D020744:rac GTP-Binding Proteins
chemical_list: C099818:DOCK1 protein, human; D050736:Oncogene Protein v-crk; D011506:Proteins; D011993:Recombinant Fusion Proteins; D015682:Retroviridae Proteins, Oncogenic; D066246:ErbB Receptors; D020744:rac GTP-Binding Proteins